Medartis saw the highest growth of 0.99% in patent filings and 0.66% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and grants by 0.66%. GlobalData’s DataBook provides a comprehensive analysis of Medartis’s patent filings and grants. Buy the databook here.
Medartis has been focused on protecting inventions in United States(US) with five publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 100% filings and 100% grants. The United States(US) patent Office are among the top ten patent offices where Medartis is filings its patents. Among the top granted patent authorities, Medartis has 100% of its grants in United States(US).
Johnson & Johnson and Globus Medical could be the strongest competitors for Medartis
In terms of grant share, Medartis stands in sixth position among its competitors. Johnson & Johnson and Globus Medical secured the top positions according to recent patent publication data.
Orthopedic devices related patents lead Medartis portfolio
Medartis has highest number of patents in orthopedic devices. For orthopedic devices, nearly 100% of patents were filed and 100% of patents were granted in Q2 2024.
For comprehensive analysis of Medartis's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.